Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis.

"SF has received speaker’s and/or scientific board honoraria from AstraZeneca, Biogen, BMS, Celgene, Janssen, Merck, Novartis and Roche; and grant support from Ruhr-University Bochum, DMSG, Stiftung für therapeutische Forschung, Lead Discovery Center GmbH and Novartis. MB and PT have received funding from the FoRUM-program of the Medical Faculty of Ruhr-University Bochum. ST has nothing to disclose. TY has received speaker honoraria from Biogen, Novartis, Chugai, Takeda, Mitsubishi-Tanabe, Miyarisan and Sumitomo Pharma; serves on the editorial boards of Therapeutic Advances in Neurological Diseases and Clinical and Experimental Neuroimmunology; receives research support from Novartis and Chiome Bioscience; and receives royalties from EA Pharma. KH has received travel grants from Biogen, Novartis and Merck; and received speaker and research honoraria from Biogen Idec Germany, Teva, Sanofi Genzyme, Novartis, Bayer Health-Care, Merck Serono and Roche. RG serves on scientific advisory boards for Teva Pharmaceutical Industries Ltd., Biogen, Bayer Schering Pharma and Novartis; has received speaker honoraria from Biogen, Teva Pharmaceutical Industries Ltd., Bayer Schering Pharma and Novartis; serves as editor for Therapeutic Advances in Neurological Diseases and on the editorial boards of Experimental Neurology and the Journal of Neuroimmunology; and receives research support from Teva Pharmaceutical Industries Ltd., Biogen Idec, Bayer Schering Pharma, Genzyme, Merck Serono and Novartis. Because RG is Editor-in-Chief of this journal, the peer review process was managed by alternative members of the Board and the submitting Editor was not involved in the decision-making process."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by a grant from the FoRUM-program of the Medical Faculty of Ruhr-University Bochum to KH and SF (F995-21), a grant from the Rose foundation T298/28150/2016 to RG and grant support from the Nasch family."